000095661 001__ 95661
000095661 005__ 20210902121743.0
000095661 0247_ $$2doi$$a10.2147/COPD.S253445
000095661 0248_ $$2sideral$$a119822
000095661 037__ $$aART-2020-119822
000095661 041__ $$aeng
000095661 100__ $$aMoya-álvarez, V.
000095661 245__ $$aVariation in assignment of the COPD patients into a GOLD group according to symptoms severity
000095661 260__ $$c2020
000095661 5060_ $$aAccess copy available to the general public$$fUnrestricted
000095661 5203_ $$aIntroduction: The Global Organization of Lung Disease (GOLD) classifies patients with chronic obstructive pulmonary disease (COPD) taking into account the symptoms. The modified Medical Research Council’s dyspnea scale (mMRC) and the COPD assessment test (CAT) are used to assess these symptoms. In this study, we analyze the concordance of GOLD classification using mMRC and CAT. Patients and Methods: This is an observational study of a cohort of 169 patients with COPD, who were classified following the GOLD 2017 recommendations, using both mMRC and CAT. A concordance analysis was applied, and a ROC curve was generated to identify the CAT score that best concorded with the mMRC scale. Results: The concordance for the GOLD groups classified by CAT and mMRC was moderate (kappa 0.492). For mMRC score of 1 and 2, a CAT score of =9 and =16 showed the maximum value of the Youden index, respectively. By reclassifying the patients with the new cut-off points obtained, the best concordance was obtained between the cut-off point for CAT of 16 and for mMRC of 2, followed by CAT of 9 and mMRC of 1. Conclusion: Because of the deficient concordance between CAT and mMRC, we propose the use of new cut-off points in future updates of the GOLD strategy.
000095661 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/
000095661 590__ $$a3.355$$b2020
000095661 591__ $$aRESPIRATORY SYSTEM$$b30 / 64 = 0.469$$c2020$$dQ2$$eT2
000095661 592__ $$a1.393$$b2020
000095661 593__ $$aHealth Policy$$c2020$$dQ1
000095661 593__ $$aPulmonary and Respiratory Medicine$$c2020$$dQ1
000095661 593__ $$aPublic Health, Environmental and Occupational Health$$c2020$$dQ1
000095661 593__ $$aMedicine (miscellaneous)$$c2020$$dQ1
000095661 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000095661 700__ $$aQuevedo-Marín, J.L.
000095661 700__ $$aJi, Z.
000095661 700__ $$aNavarro-Jiménez, C.
000095661 700__ $$aJiménez-García, R.
000095661 700__ $$aLópez-De-andrés, A.
000095661 700__ $$0(orcid)0000-0002-5553-9906$$aPérez-Trullén, Alfonso$$uUniversidad de Zaragoza
000095661 700__ $$ade Miguel-Díez, J.
000095661 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000095661 773__ $$g15 (2020), 1987-1995$$pInt. j. chronic obstr. pulm. dis.$$tInternational journal of chronic obstructive pulmonary disease$$x1176-9106
000095661 8564_ $$s2869176$$uhttps://zaguan.unizar.es/record/95661/files/texto_completo.pdf$$yVersión publicada
000095661 8564_ $$s493533$$uhttps://zaguan.unizar.es/record/95661/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000095661 909CO $$ooai:zaguan.unizar.es:95661$$particulos$$pdriver
000095661 951__ $$a2021-09-02-09:43:42
000095661 980__ $$aARTICLE